111 Inc (YI)
0.613
0.00 (0.00%)
USD |
NASDAQ |
Nov 21, 16:00
0.6113
0.00 (0.00%)
Pre-Market: 20:00
111 Debt to Equity Ratio: -0.3074 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | -0.3074 |
| March 31, 2024 | -0.3501 |
| December 31, 2023 | -0.5794 |
| September 30, 2023 | -0.6806 |
| June 30, 2023 | -0.6943 |
| March 31, 2023 | -0.6373 |
| December 31, 2022 | -0.4317 |
| September 30, 2022 | -0.6196 |
| June 30, 2022 | -0.8206 |
| March 31, 2022 | -1.019 |
| December 31, 2021 | -1.498 |
| September 30, 2021 | -1.367 |
| June 30, 2021 | 0.8891 |
| March 31, 2021 | 0.1784 |
| Date | Value |
|---|---|
| December 31, 2020 | 0.6414 |
| September 30, 2020 | 0.3713 |
| June 30, 2020 | 0.2515 |
| March 31, 2020 | 0.0589 |
| December 31, 2019 | 0.1224 |
| September 30, 2019 | 0.098 |
| June 30, 2019 | 0.0359 |
| March 31, 2019 | 0.018 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | |
| December 31, 2017 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-1.498
Minimum
Dec 2021
0.8891
Maximum
Jun 2021
-0.3417
Average
-0.4317
Median
Dec 2022
Debt to Equity Ratio Benchmarks
| Dr Reddy's Laboratories Ltd | 0.1435 |
| Zai Lab Ltd | 0.1692 |
| Concord Medical Services Holdings Ltd | -1.575 |
| Sinovac Biotech Ltd | 0.0358 |
| CASI Pharmaceuticals Inc | 1.381 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 383.75M |
| Total Liabilities (Quarterly) | 349.81M |
| Shareholders Equity (Quarterly) | -84.76M |
| Current Ratio | 1.072 |
| Net Debt Paydown Yield | 2.88% |